Data as of Jan 30
| -1.76 / -1.77%|
The 27 analysts offering 12-month price forecasts for Novartis have a median target of 103.56, with a high estimate of 119.20 and a low estimate of 73.61. The median estimate represents a +6.33% increase from the last price of 97.40.
The current consensus among 30 polled investment analysts is to Buy stock in Novartis. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.